Drug Profile
NB 003
Alternative Names: NB-003Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator NanoBio Corporation
- Class Antibacterials
- Mechanism of Action Membrane lipid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 07 May 2018 NanoBio Corporation is now called BlueWillow Biologics
- 05 Mar 2010 Phase-I clinical trials in Acne in USA (Topical)